| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 560.51M | 558.51M | 536.77M | 513.29M | 466.27M | 399.90M |
| Gross Profit | 318.06M | 142.28M | 135.76M | 164.50M | 124.21M | 96.14M |
| EBITDA | 146.72M | 129.25M | 120.24M | 147.92M | 115.41M | 90.12M |
| Net Income | 102.84M | 109.00M | 100.34M | 102.33M | 101.20M | 82.55M |
Balance Sheet | ||||||
| Total Assets | 759.43M | 777.27M | 646.78M | 586.66M | 683.74M | 580.10M |
| Cash, Cash Equivalents and Short-Term Investments | 231.80M | 258.90M | 187.15M | 161.46M | 297.69M | 242.53M |
| Total Debt | 80.32M | 81.48M | 28.26M | 18.60M | 14.97M | 20.33M |
| Total Liabilities | 331.65M | 356.20M | 290.69M | 265.91M | 266.67M | 218.60M |
| Stockholders Equity | 427.78M | 421.07M | 356.08M | 320.75M | 417.06M | 361.50M |
Cash Flow | ||||||
| Free Cash Flow | 120.92M | 137.60M | 111.00M | 81.76M | 117.74M | 98.33M |
| Operating Cash Flow | 129.26M | 144.54M | 127.35M | 93.81M | 124.57M | 103.31M |
| Investing Cash Flow | -8.34M | -6.94M | -16.36M | -12.04M | 38.18M | 5.02M |
| Financing Cash Flow | -92.80M | -65.11M | -86.01M | -215.98M | -62.75M | -88.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $1.24B | 22.81 | 29.05% | 1.04% | 9.28% | 44.19% | |
75 Outperform | $2.65B | 26.73 | 21.55% | ― | 8.99% | 35.56% | |
71 Outperform | $3.50B | 34.78 | 25.05% | 1.70% | 3.47% | -2.16% | |
71 Outperform | $4.87B | 20.07 | 13.30% | ― | -0.95% | -10.54% | |
71 Outperform | $1.66B | 15.66 | 11.09% | 0.62% | -0.47% | 10.03% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | $11.26B | 13.96 | 74.72% | 2.15% | 2.42% | 3.05% |
The recent earnings call for Exponent presented a mixed sentiment, highlighting slight revenue growth and strong litigation-related activity. However, these positives were counterbalanced by flat net revenues, decreased net income, and challenges in utilization. While there were positive developments in utility sector risk management and recruiting efforts, these were overshadowed by declines in the environmental and health segment and regulatory delays.
Exponent, Inc. is a multidisciplinary engineering and scientific consulting firm that operates across various industries, providing expertise in failure analysis and risk management. In its second quarter of 2025, Exponent reported flat revenues of $142.0 million, slightly exceeding expectations, with notable growth in dispute-related activities in the construction, automotive, and medical device sectors. However, the company faced softer demand in chemical regulatory work, impacting overall performance.
On July 31, 2025, Exponent, Inc. announced a quarterly cash dividend of $0.30 per share, to be paid on September 19, 2025, reflecting its commitment to returning value to shareholders. The company reported its second-quarter financial results for 2025, showing a slight increase in total revenues to $142.0 million, though net income decreased to $26.6 million compared to the previous year. Despite flat revenues, Exponent experienced growth in dispute-related activities in sectors like construction, automotive, and medical devices, while facing softer demand in chemical regulatory work. The firm is optimistic about opportunities in digital health, AI usability, and distributed energy systems, and anticipates continued growth in the second half of 2025.
The most recent analyst rating on (EXPO) stock is a Buy with a $120.00 price target. To see the full list of analyst forecasts on Exponent stock, see the EXPO Stock Forecast page.